Andrew Farquharson

DFJ InCube

Managing Director

Biography

Andrew is an investor and entrepreneur with 17 years of success shaping and building companies in life sciences. Andrew is also an active member of InCube Labs, where he serves as Vice President of Business Creation.

Prior to joining InCube, Andrew was an active investor with The Angels' Forum and a Partner in the Halo Funds, where he completed a Kauffman Fellowship and led investments in a portfolio of life science firms. These investments include Intrapace (obesity), Penumbra (ischemic stroke), Sonoma Orthopedic Products (bone repair), SwitchGear Genomics (gene regulation) & Spinal Modulation (pain management).

Earlier in his career, Andrew served as Senior Vice President of Sales and Marketing for QIAGEN Operon, where he grew revenues of synthetic DNA products from $13 to $40M in two years, and played a key role in selling the business for nine figures. In his earlier career, Andrew held several roles in research operations at Genentech, Inc. and co-founded a gene design business in agricultural biotechnology. He has also developed strategies for healthcare firms as a consultant.

Andrew holds a Masters of Business Administration from Harvard University and a Bachelor's with high honors from the University of California at Berkeley.